Skip to main content
Treatment intensification benefits early RA nonresponders in COBRA treat-to-target trial
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Treatment intensification benefits early RA nonresponders in COBRA treat-to-target trial
User login
Username
Password
Reset your password
Concept
Lead
score
Rheumatoid Arthritis
1
1
Arthritis
0
0.71
Specialty
Lead
score
Rheumatology
1
1
Orthopaedics
0
0.79
Edit Tags